Clinical Trial Update: The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of NouvNeu001 for Parkinson's disease, focusing on safety, feasibility, and efficacy, with the trial curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NouvNeu001

Snippet

Sponsor: iRegene Therapeutics Co., Ltd. | Conditions: Parkinson Disease (PD) | Phase 2 | Status: NOT_YET_RECRUITING